Another MR study observed that with protein-quantitative or hepatic expression instruments, ANGPTL3 downregulation robustly lowers TG and has weaker impact on apoB, with no consistent associations with CAD or ischemic stroke. Here, ANGPTL3 is linked to coronary artery disorder.